Rooney CM - Search Results

1

Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy.

Rossig C, Bollard CM, Nuchtern JG, Rooney CM, Brenner MK. Rossig C, et al. Among authors: rooney cm. Blood. 2002 Mar 15;99(6):2009-16. doi: 10.1182/blood.v99.6.2009. Blood. 2002. PMID: 11877273 Free article.

2

Transfection and gene expression in normal and malignant primary B lymphocytes.

Buschle M, Brenner MK, Chen IS, Drexler HG, Gignac SM, Rooney CM. Buschle M, et al. Among authors: rooney cm. J Immunol Methods. 1990 Oct 4;133(1):77-85. doi: 10.1016/0022-1759(90)90321-l. J Immunol Methods. 1990. PMID: 1698880

3

Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantation.

Rooney CM, Wimperis JZ, Brenner MK, Patterson J, Hoffbrand AV, Prentice HG. Rooney CM, et al. Br J Haematol. 1986 Mar;62(3):413-20. doi: 10.1111/j.1365-2141.1986.tb02952.x. Br J Haematol. 1986. PMID: 3513817

4

Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease.

Smith CA, Ng CY, Heslop HE, Holladay MS, Richardson S, Turner EV, Loftin SK, Li C, Brenner MK, Rooney CM. Smith CA, et al. Among authors: rooney cm. J Hematother. 1995 Apr;4(2):73-9. doi: 10.1089/scd.1.1995.4.73. J Hematother. 1995. PMID: 7633844

5

Gene marking after bone marrow transplantation.

Brenner MK, Rill DR, Heslop HE, Rooney CM, Roberts WM, Li C, Nilson T, Krance RA. Brenner MK, et al. Among authors: rooney cm. Eur J Cancer. 1994;30A(8):1171-6. doi: 10.1016/0959-8049(94)90478-2. Eur J Cancer. 1994. PMID: 7654451 Review. No abstract available.

6

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.

Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE. Rooney CM, et al. Lancet. 1995 Jan 7;345(8941):9-13. doi: 10.1016/s0140-6736(95)91150-2. Lancet. 1995. PMID: 7799740

7

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease.

Rooney CM, Loftin SK, Holladay MS, Brenner MK, Krance RA, Heslop HE. Rooney CM, et al. Br J Haematol. 1995 Jan;89(1):98-103. doi: 10.1111/j.1365-2141.1995.tb08904.x. Br J Haematol. 1995. PMID: 7833284

8

Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts.

Heslop HE, Brenner MK, Rooney C, Krance RA, Roberts WM, Rochester R, Smith CA, Turner V, Sixbey J, Moen R, et al. Heslop HE, et al. Hum Gene Ther. 1994 Mar;5(3):381-97. doi: 10.1089/hum.1994.5.3-381. Hum Gene Ther. 1994. PMID: 8018749 Clinical Trial. No abstract available.

9

Donor T cells to treat EBV-associated lymphoma.

Heslop HE, Brenner MK, Rooney CM. Heslop HE, et al. Among authors: rooney cm. N Engl J Med. 1994 Sep 8;331(10):679-80. doi: 10.1056/NEJM199409083311017. N Engl J Med. 1994. PMID: 8052285 No abstract available.

10

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes.

Heslop HE, Ng CY, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM. Heslop HE, et al. Among authors: rooney cm. Nat Med. 1996 May;2(5):551-5. doi: 10.1038/nm0596-551. Nat Med. 1996. PMID: 8616714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters